X
15Oct

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 3 - November 10th, 12:00 pm - 1:00 pm EST

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market. Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott’s leading life sciences lawyers. Beginning October 20, we’ll bring you a...
By: McDermott Will & Emery
Source Url: https://www.jdsupra.com/legalnews/ongoing-program-life-sciences-74285/

Related

Alert: Brexit Readiness: Possible Key Impacts of the Conclusion of the Transition Period on 31 December 2020

On 31 January 2020, the UK left the European Union and entered a transition period that is due to en...

Read More >

There Is No Delay When It Comes to FMLA: Union Workers Cannot Delay FMLA Leave According to Recent DOL Opinion Letter

The Wage and Hour Division (WHD) of the U.S. Department of Labor has issued guidance that collective...

Read More >

COVID-19: Due Diligence Considerations for M&A Transactions

Buyers in M&A transactions should consider a number of due diligence items in response to COVID-19 a...

Read More >

Prudent Process Defeats DOL

A recently released case highlights the protection afforded by a retirement plan committee that take...

Read More >

CFPB and FTC to Host December Workshop on Accuracy in Consumer Reporting

Issues affecting the accuracy of both traditional credit reports and employment and tenant backgroun...

Read More >

Supreme Court Rejects Seaman’s Claim for Punitive Damages

On June 24, 2019, the U.S. Supreme Court — in a 6 to 3 decision — held that a seaman may not recov...

Read More >